SCHEMBL29554698

SCHEMBL29554698

CCOC(=O)c1ccc(COc2cccc(C3CCN(C(=O)OC(C)(C)C)CC3)n2)c(OCC)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 3/20 0.47
POLB P06746 1/20 0.47
HPGD P15428 3/20 0.46
GPR119 Q8TDV5 3/20 0.45
ALDH1A1 P00352 3/20 0.44
NPSR1 Q6W5P4 3/20 0.44
MEN1 O00255 2/20 0.44
GAA P10253 2/20 0.44
KMT2A Q03164 2/20 0.44
LMNA P02545 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
KDM4E B2RXH2 2/20 0.43
GLP1R P43220 6/20 0.42
MAPT P10636 3/20 0.42
USP2 O75604 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24329551 1.00 TP53 (0.47) TP53POLBHPGDGPR119ALDH1A1
SCHEMBL24330478 0.92 GLP1R (0.45) TP53POLBHPGDGPR119ALDH1A1
SCHEMBL25338714 0.92 GLP1R (0.50) HPGDALDH1A1NPSR1MEN1GAA
SCHEMBL29555617 0.89 GLP1R (0.46) GLP1R
SCHEMBL29554881 0.87 GPR119 (0.47) TP53POLBHPGDGPR119ALDH1A1
SCHEMBL25956524 0.87 GPR119 (0.47) TP53POLBHPGDGPR119ALDH1A1
SCHEMBL24329558 0.87 GLP1R (0.45) TP53GPR119MEN1KMT2AGLP1R
SCHEMBL29554851 0.87 GLP1R (0.45) TP53GPR119MEN1KMT2AGLP1R
SCHEMBL25954605 0.86 GPR119 (0.44) TP53POLBGPR119MEN1KMT2A
SCHEMBL25340283 0.85 GLP1R (0.46) TP53POLBGPR119MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250263402-A1 BENZIMIDAZOLONE GLP-1 RECEPTOR AGONIST AND USE THEREOF HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO., LTD. (CN) 2025-08-21 US disclosed
EP-4227299-A1 BENZIMIDAZOLONE GLP-1 RECEPTOR AGONIST AND USE THEREOF Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. (CN) 2023-08-16 EP disclosed
WO-2022078152-A1 BENZIMIDAZOLONE GLP-1 RECEPTOR AGONIST AND USE THEREOF 杭州中美华东制药有限公司 2022-04-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250263402-A1 BENZIMIDAZOLONE GLP-1 RECEPTOR AGONIST AND USE THEREOF GLP1R, GIPR, GCGR TP53 4829/4885POLB 4863/4885HPGD 2844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.